Search Results | MSF Science Portal

Journal Article

|

Research

Apolisi I, Cox HS, Tyeku N, Daniels J, Mathee S, et al.

2023-02-21 • Open Forum Infectious Diseases

BACKGROUND
Children and adolescents with household exposure to multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) are at high risk of developing TB disease. Tuberculosis pre...

Journal Article

|

Case Report/Series

Mohr-Holland E, Daniels J, Furin J, Loveday M, Mudaly V, et al.

2021-05-01 • Pediatric Infectious Disease Journal

This brief report presents a series of 5 pregnant women treated for rifampicin-resistant tuberculosis with the novel drugs bedaquiline, delamanid, and linezolid as part of an optimized b...

Journal Article

|

Research

Mohr-Holland E, Reuter A, Furin J, Garcia-Prats AJ, De Azevedo V, et al.

2020-03-01 • eClinicalMedicine

BACKGROUND
Limited data exist on the use of bedaquiline and delamanid in adolescents with rifampicin-resistant tuberculosis (RR-TB). We describe RR-TB treatment of adolescents (10-19...

Journal Article

|

Letter

Mohr-Holland E, Hacking D, Daniels J, Scott V, Mudaly V, et al.

2021-09-01 • International Journal of Tuberculosis and Lung Disease

Journal Article

|

Commentary

Mohr-Holland E, Douglas-Jones B, Apolisi I, Ngambu N, Mathee S, et al.

2021-03-01 • Lancet Child and Adolescent Health

Science Portal

Tuberculosis diagnosis and preventive monotherapy among children and adolescents exposed to rifampicin-resistant tuberculosis in the household

Outcomes of children born to pregnant women with drug-resistant tuberculosis treated with novel drugs in Khayelitsha, South Africa: a report of five patients

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa

Diagnosis patterns for rifampin-resistant TB after onset of COVID-19

Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic